AbbVie, Genmab Secure FDA Label Expansion for Epkinly in Follicular Lymphoma

AbbVie and Genmab’s bispecific antibody Epkinly (epcoritamab) can now be used to treat patients with relapsed or refractory follicular lymphoma, based on an FDA approval on Wednesday.